The ROE (Return on Equity) of Marksans Pharma Ltd (MARKSANS.NS) is 15.26%.
ROE (Return on Equity) shows how effectively a company utilizes shareholders equity to produce earnings. It serves as a key indicator of financial return for investors.
| Date | Value |
|---|---|
| 2025-03-31 | 15.26% |
| 2024-03-31 | 15.26% |
| 2023-03-31 | 15.35% |
| 2022-03-31 | 26.61% |
| 2021-03-31 | 18.40% |
| 2020-03-31 | 14.10% |
| 2019-03-31 | 6.99% |
| 2018-03-31 | 2.03% |
| 2017-03-31 | 17.64% |